Sökning: "Sex hormone"
Visar resultat 16 - 20 av 195 avhandlingar innehållade orden Sex hormone.
16. Health-Related Quality of Life and Growth Hormone Treatment : Long-term follow-up studies of women with Turner Syndrome and women with osteoporosis
Sammanfattning : Introduction Growth Hormone (GH) is used to increase height in Turner Syndrome (TS), the most common sex-chromosome aberration in women. GH is also beneficial for bone mass. However, little is known about how GH treatment affects Health-Related Quality of Life (HRQoL). LÄS MER
17. Epidemiological and Clinical Aspects of Hormonal Contraception and Menopausal Hormone Therapy in Women
Sammanfattning : Background: The main indications for therapy with female sex hormones are contraception and menopausal hormone therapy (MHT). The aim of this thesis was to investigate the use of hormonal contraception and MHT in different populations of women in Sweden, 2000–2021. The use of contraception in women with obesity was studied. LÄS MER
18. Low back pain in women in relation to different exposures to female sex hormones
Sammanfattning : Objective: To investigate the effects of increased exposition to female sex hormones and physical strain on the prevalence of low back pain (LBP) in women. To study the etJect of increased exposition to female sex hormones on spinal sagiual mobility. LÄS MER
19. Cardiovascular mortality and morbidity in hypopituitary patients and metabolic effects of growth hormone treatment
Sammanfattning : Premature atherosclerosis, cardiovascular risk factors and increased cardiovascular mortality have been shown in patients with hypopituitarism on conventional hormone treatment, but without growth hormone (GH) replacement. The aims of paper I-III were to investigate separately the risks for cerebrovascular and cardiac mortality as well as the incidence of cardiovascular disease in patients with hypopituitarism and to assess the long-term prognosis for patients with craniopharyngioma. LÄS MER
20. Bone health and cardiovascular risk in hypopituitary patients on complete hormone replacement, including GH
Sammanfattning : Growth hormone deficiency (GHD) is associated with decreased bone mineral density (BMD). Low BMD is correlated to increased fracture risk. There are no studies on fracture risk in GHD patients on GH therapy and no studies on BMD in adults with childhood onset (CO) craniopharyngioma (CP) on GH therapy. LÄS MER